MoonLake Immunotherapeutics (MLTX) had the highest return between February 9, 2023 and March 6, 2023 by a mid-cap US stock, returning 46.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
MoonLake Immunotherapeutics (MLTX) | 2/9/2023 - 3/6/2023 | 46.15% |
BridgeBio Pharma (BBIO) | 2/9/2023 - 3/6/2023 | 43.78% |
Advantage Solutions (ADVWW) | 2/9/2023 - 3/6/2023 | 33.33% |
Lionsgate Studios Holding Corp (to be renamed Lionsgate Studios Corp) (LION) | 2/9/2023 - 3/6/2023 | 28.04% |
Sarepta Therapeutics (SRPT) | 2/9/2023 - 3/6/2023 | 27.53% |
Gulfport Energy Operating (GPOR) | 2/9/2023 - 3/6/2023 | 26.71% |
MYR (MYRG) | 2/9/2023 - 3/6/2023 | 24.07% |
Stevanato Group SpA (STVN) | 2/9/2023 - 3/6/2023 | 23.95% |
TransMedics (TMDX) | 2/9/2023 - 3/6/2023 | 23.55% |
Lantheus (LNTH) | 2/9/2023 - 3/6/2023 | 23.21% |
Apellis Pharmaceuticals (APLS) | 2/9/2023 - 3/6/2023 | 22.36% |
Dycom Industries (DY) | 2/9/2023 - 3/6/2023 | 22.19% |
Inter Parfums (IPAR) | 2/9/2023 - 3/6/2023 | 21.35% |
Remitly Global (RELY) | 2/9/2023 - 3/6/2023 | 20.88% |
Viking Therapeutics (VKTX) | 2/9/2023 - 3/6/2023 | 19.75% |
Tecnoglass (TGLS) | 2/9/2023 - 3/6/2023 | 19.43% |
AAON (AAON) | 2/9/2023 - 3/6/2023 | 19.36% |
Pegasystems (PEGA) | 2/9/2023 - 3/6/2023 | 19.18% |
Merus (MRUS) | 2/9/2023 - 3/6/2023 | 18.91% |
Intapp (INTA) | 2/9/2023 - 3/6/2023 | 18.05% |
Palomar (PLMR) | 2/9/2023 - 3/6/2023 | 17.77% |
Ast Spacemobile (ASTS) | 2/9/2023 - 3/6/2023 | 17.71% |
PBF Energy (PBF) | 2/9/2023 - 3/6/2023 | 17.66% |
Archrock (AROC) | 2/9/2023 - 3/6/2023 | 16.72% |
Grindr (GRND) | 2/9/2023 - 3/6/2023 | 16.48% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
